Posted in Government & Regulation

ADIA CEO Update: March Regulatory & Technical Update

Posted by ADIA on 25 March 2026
ADIA CEO Update: March Regulatory & Technical Update

Welcome to your monthly TGA and technical update. As your industry representative, your views shape the responses we make to consultations on everything from fees and charges to patient safety and sharing of your medical device data. If you have feedback on regulatory and technical matters, please get in contact at any time

What would the TGA Conformity Assessment Proposal mean for you?

This consultation has 8 proposals with wide-reaching impacts including the up-classifying of reusable surgical instruments and annual reporting for Class IIb and above medical devices. You can access the recording from the information session.

If your business has Class IIb medical devices registered with the TGA, including dental implants and abutments, autoclaves and washer/disinfectors, these proposals will impact you.

The deadline has been extended due to the complexity of the consultation and there is still time to respond. The consultation closes 31 March 2026. You can make your own submission via the link or send any comments you would like included in the ADIA submission by 20 March 2026.

Updates to the AusUDID

Improvements to the online portal and machine to machine HL7 SPL submission method are now live on the AusUDID portal. You can view the Release Notes for more information.

The AusUDID Grace Period in the AusUDID Production environment has been extended from 7 days to 30 days, allowing  additional time to correct any errors from the early stages of the AusUDID data loading.

Guidance for Surgical Loan Kits has also been published.

Non-compliance on Annual Reporting can lead to ARTG cancellation

Annual reports for Class III and Class IIb devices for the first 3 years of inclusion on the ARTG are mandatory and are due on 1 October each year. The TGA is actioning compliance measures including ARTG cancellation for Sponsors who fail to submit on time.

You can find guidance on submitting annual reports here.

Product Recalls, Alerts and Corrections (PRAC)

New resources are now available, including FAQsguidance on compliance, and minor changes to the PRAC, available here.

Adverse Event Terminology updated by IMDRF

Updated Adverse Event terminology, including revised terms, definitions and codes, has now been published on the IMDRF website.

Medical device supply disruptions from the Middle East

The TGA is monitoring disruptions or impacts to the supply of medical devices to Australia. If you are aware of disruptions or impacts from recent developments, please let the TGA know by emailing MD.SupplyDisruptions@health.gov.au.

We will continue to provide you with technical updates each month.

Posted in:TGAIndustry NewsNews & MediaCEO UpdatesGovernment & Regulation  

ADIA CEO Update: February Regulatory & Technical Update

Posted by ADIA on 12 February 2026
ADIA CEO Update: February Regulatory & Technical Update

Welcome to your monthly TGA and technical update. As your industry representative, your views shape the responses we make to consultations on everything from fees and charges to patient safety and sharing of your medical device data. If you have feedback on regulatory and technical matters, please get in contact at any time

Would increased TGA fees impact heavily on your business?

The TGA operates on a cost recovery basis to fund the regulation of Therapeutic goods, including medical devices. Unlike last year, the TGA is proposing significant increases to the annual fees and charges in 2026-27.

The TGA is proposing two options - partial recovery and full recovery resulting in proposed increases of TGA fees by 4.3 or 4.8% respectively and annual charges by 4.0-4.2% or 6.1-6.3% respectively.

Please provide your feedback with specific examples of the hardship that higher fees and charges from full recovery would impose on your business. This will enable us to build the case to support the adoption of the lower fees and charges. You can respond directly to the TGA or send your feedback to us by 9am on Monday 23 Feb 2026.


Important changes to AS/NZ 5369 - Small Steam Sterilisers

Standards Australia has released an Amendment for AS/NZS 5369:2023, which will primarily affect small steam sterilisers (with chambers < 60 L).

The main change is that references to "Bowie and Dick-type tests" have been replaced with Air Removal and Steam Penetration Tests (ARSPT). For small steam sterilisers (chamber < 60 L), the amendment requires that the manufacturer's instructions (user manual) are followed to determine what type of ISO 11140-6 compliant ARSPT (porous device or hollow device) should be performed daily.

For large sterilisers (chamber > 60 litres) a Bowie-Dick type test that conforms with ISO 11140-3, ISO 11140-4, or ISO 11140-5 must still be performed daily.

If you require further information, please contact us.


The Australian Ethical Health Alliance (AEHA)

The AEHA is a working group for SMEs who manufacture or supply pharmaceuticals or medical devices that focuses on ethical challenges to enter or stay in the market. If you would like more information or would be willing to participate in a roundtable to discuss the challenges you face with regard to ethics, please contact us by COB Friday 13 February.

Would you be happy to share your proprietary device information?

As part of a proposal to improve transparency in situations of medical device supply disruptions, the TGA has a proposal to release information to other parties, including alternative device sponsors in an effort to protect continuity of patient care.

Would you be happy to share your proprietary medical device information with your competitors? You can read the full consultation paper and respond directly to the TGA or send your feedback to us by 9am on Wednesday 18 Feb 2026.


TGA changes to conformity assessment procedures

TGA has proposed amendments to conformity assessment procedures for medical devices, as part of An Action Plan for Medical Devices and the ongoing Medical Device Reform program. You can access the recording from the information session.

The consultation closes 27 February 2026. You can make your own submission via the link or send any comments you would like included in the ADIA submission by 20 February 2026.

Digital Transformation of the TGA portal

 

You can still have your say about the TGA’s TBS business portal (Beta release). It’s not too late to visit the test site TGA website and provide feedback via a survey form until 28 February 2026.

We will continue to provide you with technical updates each month.

Posted in:TGAIndustry NewsNews & MediaCEO UpdatesGovernment & Regulation  

ADIA CEO Update: January Regulatory & Technical Update

Posted by ADIA on 15 January 2026
ADIA CEO Update: January Regulatory & Technical Update

To ensure that you can stay up-to-date with the ongoing TGA Medical Device Reform program and any other regulatory information, we will be bringing you regular updates each month. If you have any feedback on regulatory and technical processes, changes or issues, please get in contact at any time.

UDI changes to Consent to Supply

The TGA is proposing a streamlined approach for sponsors unable to meet the UDI requirements including options for a reduced fee. Find out more and access the UDI Consent to Supply consultation. General UDI information and guidance can be found at the UDI Hub.

Submissions close:  23 January 2026.

You can make your own submission via the link or send any comments you would like included in the ADIA submission by 19 January 2026.

Public consultation on TGA Conformity assessment procedures

TGA is undertaking a public consultation on proposed amendments to conformity assessment procedures for medical devices, as part of An Action Plan for Medical Devices and the ongoing Medical Device Reform program.

The consultation closes 27 February 2026.

You can make your own submission via the link or send any comments you would like included in the ADIA submission by 20 February 2026.

Boundary and Combination Products

Toothpastes are among the Boundary and Combination products that have undergone recent regulatory changes based on their principal intended action starting on 1 January 2026.

From this date new ARTG inclusions must be entered under the correct regulatory pathway at the time of inclusion. Existing ARTG entries will have a five year transition period until 31 December 2030.

Find out more here.

TGA Regulatory engagement meetings

Did you know that you can access these meetings to discuss the regulatory requirements for your medical device?

Meetings can be accessed from the start of  medical device development all the way to seeking inclusion in the ARTG. They can help to navigate the regulatory requirements and pathways, understand the supporting information needed for an application and identify any issues before applying. TGA are keen to engage early to ensure a more seamless path to approval.

For more information, visit the TGA here.

Digital Transformation of the TGA portal - Beta release

You can access videos of the new system, featuring a refreshed TBS portal, GMP clearance form and Case Management Solution on the TGA website.

You can provide feedback via a survey form until 28 February 2026.

Save the date for the next ADIA Technical forum

Tuesday 31 March 2026
1-2pm

  • Join Dr Joanne Challinor-Rogers, Ms Clare Martin and Dr Sarah Raphael for the latest TGA Updates following the first 2026 Reg Tech Meeting in Canberra.
  • Email any technical questions ahead of time to have them addressed during the forum
  • Any questions, email advocacy@adia.org.au or phone Dr Sarah Raphael on 0412 918 8484

We look forward to sharing more news on all the important ADIA projects, advocacy and events throughout the year.

Posted in:TGAIndustry NewsNews & MediaCEO UpdatesGovernment & Regulation  

ADIA Advocacy Update: August 2025

Posted by ADIA on 12 August 2025
ADIA Advocacy Update: August 2025

There has been plenty of recent activity in the Advocacy Space. Last week during Dental Health Week, ADIA held its second Adelaide Dental Symposium and hosted a South Australian Dental Service key stakeholder, Ms Kristy Nixon. Kym De Britt, CEO provided a guided tour of the Exhibition, showcasing our members' innovative technology, that is facilitating dental treatment outside of traditional dental clinics, including mobile dental carts, scanners and 3D printers.

In other news, ADIA has been met with several other dental sector association leaders, including Nathan Clarke, the CEO of the newly-formed Oral Health Association of Australia (OHAA). OHAA has formed from the merger of Dental Hygienists Association of Australia (DHAA) and the Australian Dental and Oral Health Therapists Association (ADOHTA). In addition, ADIA participated in final workshop for the development of the next National Oral Health Plan which sets out the strategic focus for improvements in Australia’s oral health over the next decade.

ADIA has partnered with Colgate on two projects to raise the awareness of the Child Dental Benefits Schedule to eligible families. Firstly, including our ADIA CDBS Information brochures in Foodbank NSW School Breakfast Hampers (pictured) and also within G8 Early Learning Centres.

Our Director of Policy and Education, Dr Sarah Raphael and Technical Team member, Dr Joanne Challinor-Rogers participated in the Medical Technology Association of Australia, Regulatory Summit in July. To catch the regulatory information from the summit, which included global and TGA presenters, as well as news from the forthcoming TGA Regulatory and Technical Forum, join the Technical Forum at 1pm on Tuesday 2nd September. Register here

To get involved in ADIA Advocacy or share your thoughts and ideas, please contact Dr Sarah Raphael by emailingsarah.raphael@adia.org.au

ADIA Brochures and Colgate Education kits being prepared for the Foodbank NSW Breakfast program.

Posted in:Industry NewsGovernment & RegulationAdvocacy  

Standards Australia Consultation - August 2025

Posted by ADIA on 29 July 2025
Standards Australia Consultation - August 2025

STANDARDS AUSTRALIA CONSULTATION: DR AS/NZS 5369:2023 AMENDMENT

Standards Australia have a current consultation open until 22 September 2025 on amendments to:

DR AS/NZS 5369:2023 Reprocessing of reusable medical devices and other devices in health and non-health related facilities.

These amendments are centred on updates that result from the amendment of ISO 11139:2018/Amd 1:2024, 3.214.2 including impacts on sterilzation processes and process challenge devices.

To review the proposed amendment to the Standard, you are required register with Standards Australia. All comments are made online via the consultation portal.

Please follow these steps to provide your feedback.

Register and Log in

  1. Visit Standards Australia
  2. Hover on Committee Access - the blue heading on the top right of the menu bar.
  3. Click on Public Comment where the list of open consultations will be listed.
  4. Type "5369" in the Search Drafts bar.
  5. If you are registered for Standards Australia - log on here. If you are not registered you can follow the prompts to register.

Providing feedback

Once you have registered and logged in:

  1. Click on DR AS/NZS 5369:2023 Amd 1:2025.
  2. Comments can be made throughout the sections of the document by either:
  • Clicking the sections on the Table of Contents; or
  • By using the Previous and Next buttons on the top right corner; or
  • Comments can be made by clicking on the Add Comment button at the end of each section.
  • Alternately, general comments can be made at the bottom of the "Draft Details" page.

Need help?

Additional help is available at the Help Guide to assist in navigating the Public Comment Portal.


If you require further information please email ADIA Director of Policy and Education, Dr Sarah Raphael

Posted in:Industry NewsGovernment & RegulationAdvocacy  

Sign up for our latest news and events

Contact Us

Follow Us On